Whole-body MRI in follow-up of patients with renal cell carcinoma

Acta Radiologica

Volumn 51, Issue 5, 2010, Pages 581-589

  Platzek, Ivan ^a   Zastrow, Stefan ^a   Deppe, Pierre Emanuel ^a   Grimm, Marc Oliver ^a   Wirth, Manfred ^a   Laniado, Michael ^a   Stroszczynski, Christian ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Computed tomography; CT; Staging

Indexed keywords

CEREBRAL METASTASIS; CLINICAL UTILITY; COMPUTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC PERFORMANCE; LYMPH NODE METASTASIS; MULTISLICE CT; PULMONARY NODULES; RENAL CELL CARCINOMA; TECHNOLOGICAL ADVANCES; WHOLE-BODY;

PATHOLOGY;

COMPUTERIZED TOMOGRAPHY;

CONTRAST MEDIUM; DIAGNOSTIC AGENT; DRUG DERIVATIVE; GADOLINIUM PENTETATE; IOHEXOL; IOPROMIDE;

ADULT; AGED; ARTICLE; COMPARATIVE STUDY; COMPUTER ASSISTED DIAGNOSIS; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; KIDNEY CARCINOMA; KIDNEY TUMOR; LYMPH NODE METASTASIS; MALE; METHODOLOGY; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PROSPECTIVE STUDY; RADIOGRAPHY; SENSITIVITY AND SPECIFICITY; WHOLE BODY IMAGING;

ADULT; AGED; CARCINOMA, RENAL CELL; CONTRAST MEDIA; FEMALE; GADOLINIUM DTPA; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; IOHEXOL; KIDNEY NEOPLASMS; LYMPHATIC METASTASIS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED; WHOLE BODY IMAGING;

EID: 77952724098     PISSN: 02841851     EISSN: 16000455     Source Type: Journal    
DOI: 10.3109/02841851003724846     Document Type: Article

References (30)

1. Lindblad P. Epidemiology of renal cell carcinoma. Scand J Surg 2004;93:88-96.
2. Lipworth L, Tarone RE, McLaughlin JK. The epidemiology of renal cell carcinoma. J Urol 2006;176:2353-8.
3. Stephenson AJ, Chetner MP, Rourke K, Gleave ME, Signaevsky M, Palmer B, et al. Guidelines for the surveillance of localized renal cell carcinoma based on the patterns of relapse after nephrectomy. J Urol 2004;172:58-62.
4. Sorbellini M, Kattan MW, Snyder ME, Reuter V, Motzer R, Goetzl M, et al. A postoperative prognostic nomogram predicting recurrence for patients with conventional clear cell renal cell carcinoma. J Urol 2005;173:48-51.
5. Israel GM, Bosniak MA. Renal imaging for diagnosis and staging of renal cell carcinoma. Urol Clin North Am 2003;30:499-514.
6. Lawrentschuk N, Gani J, Riordan R, Esler S, Bolton DM. Multidetector computed tomography vs magnetic resonance imaging for defining the upper limit of tumour thrombus in renal cell carcinoma: a study and review. BJU Int 2005;96:291-5.
7. Yerram P, Saab G, Karuparthi PR, Hayden MR, Khanna R. Nephrogenic systemic fibrosis: a mysterious disease in patients with renal failure - Role of gadolinium-based contrast media in causation and the beneficial effect of intravenous sodium thiosulfate. Clin J Am Soc Nephrol 2007;2:258-63.
8. Greene FL, American Joint Committee on Cancer, American Cancer Society. AJCC cancer staging manual. Sixth edition. New York: Springer-Verlag; 2002.
9. Dorfman RE, Alpern MB, Gross BH, Sandler MA. Upper abdominal lymph nodes: criteria for normal size determined with CT. Radiology 1991;180:319-22.
10. Glazer GM, Gross BH, Quint LE, Francis IR, Bookstein FL, Orringer MB. Normal mediastinal lymph nodes: number and size according to American Thoracic Society mapping. Am J Roentgenol 1985;144:261-5.
11. van den Brekel MW, Stel HV, Castelijns JA, Nauta JJ, van der Waal I, Valk J, et al. Cervical lymph node metastasis: assessment of radiologic criteria. Radiology 1990;177:379-84.
12. Zerhouni EA, Stitik FP, Siegelman SS, Naidich DP, Sagel SS, Proto AV, et al. CT of the pulmonary nodule: a cooperative study. Radiology 1986;160:319-27.
13. Vanel D, Bittoun J, Tardivon A. MRI of bone metastases. Eur Radiol 1998;8:1345-51.
14. Sturgeon C, Shen WT, Clark OH, Duh QY, Kebebew E. Risk assessment in 457 adrenal cortical carcinomas: how much does tumor size predict the likelihood of malignancy? J Am Coll Surg 2006;202:423-30.
15. Antonelli A, Cozzoli A, Zani D, Zanotelli T, Nicolai M, Cunico SC, et al. The follow-up management of non-metastatic renal cell carcinoma: definition of a surveillance protocol. BJU Int 2007;99:296-300.
16. Majhail NS, Urbain JL, Albani JM, Kanvinde MH, Rice TW, Novick AC, et al. F-18 fluorodeoxyglucose positron emission tomography in the evaluation of distant metastases from renal cell carcinoma. J Clin Oncol 2003;21:3995-4000.
17. Miyakita H, Tokunaga M, Onda H, Usui Y, Kinoshita H, Kawamura N, et al. Significance of 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) for detection of renal cell carcinoma and immunohistochemical glucose transporter 1 (GLUT-1) expression in the cancer. Int J Urol 2002;9:15-18.
18. Muller-Horvat C, Radny P, Eigentler TK, Schafer J, Pfannenberg C, Horger M, et al. Prospective comparison of the impact on treatment decisions of whole-body magnetic resonance imaging and computed tomography in patients with metastatic malignant melanoma. Eur J Cancer 2006;42:342-50.
19. Antoch G, Vogt FM, Freudenberg LS, Nazaradeh F, Goehde SC, Barkhausen J, et al. Whole-body dual-modality PET/CT and whole-body MRI for tumor staging in oncology. JAMA 2003;290:3199-206.
20. Schmidt GP, Baur-Melnyk A, Herzog P, Schmid R, Tiling R, Schmidt M, et al. High-resolution whole-body magnetic resonance image tumor staging with the use of parallel imaging versus dual-modality positron emission tomography-computed tomography: experience on a 32-channel system. Invest Radiol 2005;40:743-53.
21. Karabulut N, Martin DR, Yang M, Tallaksen RJ. MR imaging of the chest using a contrast-enhanced breathhold modified three-dimensional gradient-echo technique: comparison with two-dimensional gradient-echo technique and multidetector CT. Am J Roentgenol 2002;179:1225-33.
22. Schafer JF, Vollmar J, Schick F, Seemann MD, Kamm P, Erdtmann B, et al. [Detection of pulmonary nodules with breath-hold magnetic resonance imaging in comparison with computed tomography.] Rofo 2005;177:41-9. (in German).
23. Luboldt W, Wetter A, Eichler K, Vogl TJ, Wagner TO, Seemann MD. Determination of the optimal MRI sequence for the detection of malignant lung nodules. Eur J Med Res 2006;11:336-42.
24. Ergen FB, Hussain HK, Caoili EM, Korobkin M, Carlos RC, Weadock WJ, et al. MRI for preoperative staging of renal cell carcinoma using the 1997 TNM classification: comparison with surgical and pathologic staging. Am J Roentgenol 2004;182:217-25.
25. Culine S, Bekradda M, Kramar A, Rey A, Escudier B, Droz JP. Prognostic factors for survival in patients with brain metastases from renal cell carcinoma. Cancer 1998;83:2548-53.
26. Pomer S, Klopp M, Steiner HH, Brkovic D, Staehler G, Cabillin-Engenhart R. [Brain metastases in renal cell carcinoma. Results of treatment and prognosis.] Urologe A 1997;36:117-25. (in German).
27. Casalino DD, Francis IR, Baumgarten DA, Bluth EI, Bush WH Jr, et al. Expert Panel on Urologic Imaging. Follow-up of renal cell carcinoma. [online publication]. Reston (VA): American College of Radiology (ACR); 2007. [Available from http://www.guideline.gov/summary/summary.aspx?ss=15&doc-id= 11570&nbr=5994].
28. Seaman EK, Ross S, Sawczuk IS. High incidence of asymptomatic brain lesions in metastatic renal cell carcinoma. J Neurooncol 1995;23:253-6.
29. Marshall ME, Pearson T, Simpson W, Butler K, McRoberts W. Low incidence of asymptomatic brain metastases in patients with renal cell carcinoma. Urology 1990;36:300-2.
30. Walter C, Kruessell M, Gindele A, Brochhagen HG, Gossmann A, Landwehr P. Imaging of renal lesions: evaluation of fast MRI and helical CT. Br J Radiol 2003;76:696-703.